Urology Testing

Our team of urologic pathologists provide academic-caliber, definitive diagnoses. Our pathologists utilize advanced, in-house testing, including comprehensive Immunohistochemistry (IHC) panels, to supplement morphological evaluations of difficult cases.

Test Offering Test Details Category Indications
Prostate biopsy evaluation Prostate biopsy evaluation, Prostate cancer Nomograms (Partin and Han tables) Prostate Prostate cancer detention
PIN-ERG Multiplex ERG, basal cell markers, and AMACR IHC Prostate To improve prostate cancer detection and resolve Atypical diagnosis in prostate biopsies
PINgenius Following diagnosis of HGPIN, uses biomarker overexpression as well as several histological factors Prostate To predict the risk of prostate cancer at re-biopsy
Bladder biopsies Mucosal cup biopsies and transurethral resection of bladder tumor Bladder Bladder cancer detection
Tumor of uncertain origin A panel of PSA, PSMA, ERG, p63, HMWCK, Uroplakin IHC markers Prostate and bladder
Urothelial dysplasia panel A panel of CK20, Ki-67, P53 and CD44 IHC Bladder Differentiation of urothelial dysplasia/CIS from reactive and therapy atypia
Urine/bladder and renal pelvic wash cytology Cytomophologic anlysis of Urothelial cells Bladder Bladder cancer detection
UroVysion test FISH measurement of chromosome 3,7,17 and loss of 9p in urothelial cells secreted in urine Bladder To improve bladder cancer detection complementing urine cytology
Testis biopsy Histological analysis of testis biopsy Testis Infertility evaluation
Testis tumor evaluation Complete evaluation of tumor with utilization of germ cell markers IHC when applicable Testis Evaluation of a mass lesion
Stone evaluation Chemical analysis of stone Kidney, Bladder To determine chemical composition of stone
Renal mass biopsy evaluation Classification of renal tumor in biopsy with application of select tumor markers panel Kidney To aid in treatment decision for renal mass management
Skin biopsy and resections Evaluation of skin lesions affecting penis/scrotum and perineal area Penis, Scrotum Evaluation of a skin lesion or mass
HPV genotype In situ hybridization studies of low and high risk HPV Penis, Scrotum To determine HPV risk potential

Download as PDF

Outstanding Service


“We have been using Miraca for about 20 months, and they are outstanding.”

– Joel Cohen, MD

Learn More »

I recommend using [Miraca’s] laboratory and physicians most highly and without reservation.
— Michael H. Coverman, MD,
Austin Dermatology Clinic, PA, Austin, Texas


READ MORE
Learn about Miraca's unmatched quality. We provide our clients with access to the highest quality AP services.